State and local officials are secretly seeking a multimillion dollar package of tax incentives to entice Baxter International, a Fortune 500 pharmaceutical company based in Illinois, to begin operations in Minnesota, MPR reports.
The Star Tribune says Baxter's planned expansion in Brooklyn Park could bring nearly 200 high-paying jobs to the Twin Cities metro.
Legislators are considering more than $15 million in taxpayer subsidies for the biotech firm, according to the Associated Press.
Gov. Mark Dayton declined to name the "mystery" firm on Tuesday, but Brooklyn Park City Manager Jamie Verbrugge later confirmed to MinnPost that Baxter International was the interested company.
Baxter International paid nearly $10 million for a long-idled former biotech facility in Brooklyn Park earlier this year. That's where it plans to complete a two-phase renovation project that could total more than $300 million.